OssDsign News and Activities

OssDsign is owned by KDventures.

KDventures is a company listed under the stock ticker KDEV (SE).

They are in:

• Holding33%
• Medical Equipment33%
• Other33%

Acquisition, funding and merger involving KDventures.

• Karolinska Development will change its company name to KDventures on Feb 10, 2026. (posted on February 10 2026).
• KDventures has filed its IPO. Its stock ticker will be KDV. (posted on January 29 2026).

View the org chart displaying its 15 main executives

Most searched biographies at OssDsign

• Mark Waugh, Chief Executive Officer
• Simon Cartmell, Chairman of the Board
• David Jern, Board Member

Popular executive movements at OssDsign

• Adam Mccollister has joined the company as Vice President of Sales  (posted on June 29 2026).
• Mark Waugh will join the company as Chief Executive Officer on Jan. 1, 2026  (posted on December 10 2025).

Create your alert
to follow the executive moves at OssDsign.

KDventures has 1,246 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Medtronic (Ireland).

Popular M&A news in Medical Equipment

• CVC Capital Partners has announced the acquisition of WillowWood  (posted on June 18 2026).
• Spectrum Vascular has acquired Piccolo Medical (posted on June 17 2026).
• Medtronic has acquired Scientia Vascular (posted on June 14 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific

Learn more about the Medical Equipment industry

Press releases by OssDsign

• News - OssDsign AB
• OssDsign appoints Tom Buckland as Chief Technical Officer
• OssDsign AB (publ) publishes year-end report 2023
• 12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research
• OssDsign - Giving patients back the life they deserve
• OssDsign reports exceptional data from the clinical study TOP FUSION
• Regulatoriska Pressmeddelanden - OssDsign AB
• SEB Venture Capital has sold its holding in OssDsign
• OssDsign changes Certified Adviser to Carnegie Investment Bank AB (publ)
• OssDsign’s revenues for the fourth quarter of 2023 are expected to exceed market estimates
• View more press releases Close

Social media about OssDsign

• OssDsign on Wikipedia, Google News & Yahoo Finance
• OssDsign on LinkedIn, X (Twitter) & YouTube